A`

Global Digital
Biomarkers
Market - A Global
and Regional
Analysis
Table of Content

https://www.shutterstock.com/image-photo/mri-image-head-showing-brain-227580421

Focus on System Component, Type,

Application, End User, Regional and
Country-Wise Analysis

Analysis and Forecast:2022-2028

April 2022

All rights reserved at BIS Research Inc. 1

BIS Research is a leading market intelligence and technology research company. BIS Research publishes
in-depth market intelligence reports focusing on market estimations, technology analysis, emerging high-
growth applications, deeply segmented granular country-level market data, and other important market
parameters useful in the strategic decision making for senior management. BIS Research provides multi-
client reports, company profiles, databases, and custom research services.

Copyright © 2022 BIS Research Inc.

All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the
people or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to
any third party.

All rights reserved at BIS Research Inc. 2

Table of Content
Executive Summary ....................................................................................30
Scope of the Study .....................................................................................39
Research Methodology ..............................................................................41
1. Markets .................................................................................................47
1.1 Market Outlook................................................................................................. 47
1.1.1 Product Definition ....................................................................................... 47
1.1.1.1 Data Collection Tools......................................................................................... 47

1.1.1.1.1 Wearable Devices ................................................................................................... 47

1.1.1.1.2 Implantables ............................................................................................................ 47

1.1.1.1.3 Mobile Applications ................................................................................................ 48

1.1.1.2 Data Integration Software .................................................................................. 48

1.1.2 Inclusion and Exclusion Criteria ................................................................ 48

1.1.3 Key Findings ................................................................................................ 49
1.1.4 Global Market Scenario............................................................................... 49
1.1.4.1 Realistic Growth Scenario ................................................................................. 49

1.1.4.2 Optimistic Growth Scenario ............................................................................... 50

1.1.4.3 Pessimistic/Conservative Growth Scenario ....................................................... 51

1.2 Global Digital Biomarkers Market Overview.................................................. 52

1.2.1 Current State of Digital Biomarker ............................................................. 52
1.2.2 Types of Biomarkers ................................................................................... 53
1.2.2.1 Wellness ............................................................................................................ 53

1.2.2.2 Disease .............................................................................................................. 53

1.2.2.3 Drugs ................................................................................................................. 53

1.2.3 Industry ........................................................................................................ 54

1.2.3.1 Pharmaceutical .................................................................................................. 54

1.2.3.2 Biotechnology/Life Sciences .............................................................................. 54

1.2.3.3 Medical Devices................................................................................................. 55

1.2.3.4 Application Vendors ........................................................................................... 55

1.2.4 Clinical Trials (Clinical Research Organization) ....................................... 55

All rights reserved at BIS Research Inc. 3

 1.2.4.1 Technology Vendors .......................................................................................... 56

1.2.5 Digital Biomarker Ecosystem ..................................................................... 56

1.2.5.1 Wearable Devices.............................................................................................. 57

1.2.5.2 Implantable Components/ Sensors .................................................................... 59

1.2.5.3 Ocular Devices .................................................................................................. 59

1.2.5.4 Accelerometers .................................................................................................. 60

1.2.5.5 Smart Home Systems/IoTs ................................................................................ 60

1.2.5.6 AR/VR Platforms................................................................................................ 60

1.2.5.7 Desktop/Web Applications ................................................................................. 61

1.2.6 Data Measurement....................................................................................... 61

1.2.6.1 Physiological Parameters .................................................................................. 61

1.2.6.2 Behavioral Parameters ...................................................................................... 61

1.3 Industry Outlook .............................................................................................. 62

1.3.1 Technology Landscape ............................................................................... 62
1.3.1.1 Artificial Intelligence and Machine Learning ...................................................... 62

1.3.1.2 Augmented Reality (AR) and Virtual Reality (VR) ............................................. 63

1.3.1.3 Blockchain ......................................................................................................... 63

1.3.1.4 Edge Computing ................................................................................................ 64

1.3.1.5 Cloud Computing ............................................................................................... 64

1.3.2 Key Trends ................................................................................................... 65

1.3.3 Opportunity Assessment ............................................................................ 66
1.3.3.1 Short-Term Growth Potential ............................................................................. 66

1.3.3.2 Long-Term Growth Potential.............................................................................. 67

1.3.4 Product Benchmarking ............................................................................... 67

1.3.5 Patent Analysis ............................................................................................ 68
1.3.5.1 Awaited Technological Developments ............................................................... 68

1.3.5.2 Patent Publication Growth Trend ....................................................................... 69

1.3.5.3 Patent Analysis (by Country/Cluster) ................................................................. 70

1.3.6 Case Studies: Key Therapeutic Areas ....................................................... 70

1.3.6.1 Cardiovascular Diseases ................................................................................... 70

All rights reserved at BIS Research Inc. 4

 1.3.6.2 Parkinson’s Diseases ........................................................................................ 71

1.3.6.3 Alzheimer’s Diseases ........................................................................................ 72

1.4 Impact of COVID-19 ......................................................................................... 72

1.4.1 Impact on Digital Biomarkers ..................................................................... 72
1.4.2 Impact on Device Adoption ........................................................................ 74
1.4.3 Impact on Market Size ................................................................................. 77
1.4.3.1 Pre-COVID-19 Phase ........................................................................................ 77

1.4.3.1.1 Global and Regional Analysis .................................................................................. 77

1.4.3.2 During COVID-19 Phase ................................................................................... 79

1.4.3.2.1 Global and Regional Analysis .................................................................................. 79

1.4.3.3 Post-COVID-19 Phase....................................................................................... 81

1.5 Business Dynamics ......................................................................................... 81

1.5.1 Impact Analysis ........................................................................................... 81
1.5.2 Business Drivers ......................................................................................... 82
1.5.2.1 Rising Popularity of Digital Biomarkers in Drug Development ........................... 82

1.5.2.2 Rising Employment of Vocal Digital Biomarkers ................................................ 83

1.5.2.3 Rising Use of Wearable Devices and Increasing Smartphone Penetration ....... 83

1.5.2.4 Regulatory Flexibility toward Digital Health Solutions ........................................ 85

1.5.2.5 Failure of Drugs for Neurodegenerative Disorders ............................................ 85

1.5.3 Business Challenges .................................................................................. 86

1.5.3.1 Need for Standardized and Interoperable Solutions .......................................... 86

1.5.3.2 Inaccuracy in Data Measurements .................................................................... 88

1.5.3.3 Lack of Integration and Interoperability between Medical Records and

User Generated Data......................................................................................... 88

1.5.3.4 Lack of Use Cases of the Return on Investment (ROI) Analysis ....................... 88

1.5.4 Business Opportunities .............................................................................. 89

1.5.4.1 Digital Biomarkers: The Future of Precision Medicine ....................................... 89

1.5.4.2 Early Detection of Neurological Disorders Using Digital Biomarkers ................. 89

1.5.4.3 Increasing Awareness for General Health Management ................................... 90

1.5.4.4 Upsurge in Demand of Metabolic, Cardiovascular, and Gastrointestinal

Healthcare ......................................................................................................... 90
All rights reserved at BIS Research Inc. 5
 1.5.4.5 Penetration of Digital Biomarkers in Female, Maternal, Pre- and Neo-
Natal Care.......................................................................................................... 91

1.5.4.6 Rise in Usage of Digital Biomarkers to Assess Pulmonary Health .................... 92

2. Global Digital Biomarker Market (by Application) ............................93

2.1 Opportunity Assessment ................................................................................ 93
2.2 Growth-Share Matrix ....................................................................................... 95
2.3 Gastrointestinal Diseases ............................................................................... 96
2.4 Sleep and Movement Disorders ................................................................... 100
2.5 Cardiovascular ............................................................................................... 102
2.6 Psychiatric Disorders (Mood and Behavior) ............................................... 105
2.7 Chronic Pain................................................................................................... 107
2.8 Neurodegenerative Diseases ........................................................................ 109
2.9 Diabetes .......................................................................................................... 112
2.10 Respiratory Diseases .................................................................................... 114
2.11 Others ............................................................................................................. 116
3. Global Digital Biomarkers Market (by End User) ............................117
3.1 Opportunity Assessment .............................................................................. 117
3.2 Growth-Share Matrix ..................................................................................... 118
3.3 Biopharmaceutical Companies .................................................................... 119
3.4 Payers ............................................................................................................. 120
3.5 Providers ........................................................................................................ 121
4. Global Digital Biomarkers Market (by System Components) ........123
4.1 Opportunity Assessment .............................................................................. 123
4.2 Market Share Analysis .................................................................................. 124
4.3 Growth-Share Matrix ..................................................................................... 125
4.4 Data Collection Tools .................................................................................... 126
4.4.1 Wearables Devices .................................................................................... 126
4.4.1.1 Evolution of Wearable Devices in Clinical Trials .............................................. 128

4.4.1.2 Wearable Devices in Clinical Trials ................................................................. 128

4.4.1.3 Actigraphy Devices .......................................................................................... 129

All rights reserved at BIS Research Inc. 6

 4.4.1.4 Opportunity in Digital Biomarker ...................................................................... 130

4.4.1.5 New Developments .......................................................................................... 131

4.4.1.6 Market Estimation and Forecast ...................................................................... 131

4.4.2 Implantables .............................................................................................. 132

4.4.2.1 Opportunity in Digital Biomarker ...................................................................... 132

4.4.2.2 New Developments .......................................................................................... 132

4.4.2.3 Market Estimation and Forecast ...................................................................... 133

4.4.3 Mobile Applications................................................................................... 134

4.4.3.1 Opportunity in Digital Biomarkers .................................................................... 135

4.4.3.2 New Developments .......................................................................................... 136

4.4.3.3 Market Estimation and Forecast ...................................................................... 136

4.5 Data Integration Software ............................................................................. 137

4.5.1 Opportunity in Digital Biomarker ............................................................. 139
4.5.2 New Developments.................................................................................... 139
4.5.3 Market Estimation and Forecast .............................................................. 139
5. Global Digital Biomarkers Market (by Type) ...................................140
5.1 Opportunity Assessment .............................................................................. 140
5.2 Market Share Analysis .................................................................................. 141
5.3 Growth-Share Matrix ..................................................................................... 142
5.4 Clinical Trials ................................................................................................. 143
5.5 Clinical Settings ............................................................................................. 144
6. Region ................................................................................................145
6.1 North America Digital Biomarkers Market ................................................... 145
6.1.1 Regulatory Framework.............................................................................. 145
6.1.2 Opportunity Assessment .......................................................................... 146
6.1.3 Market Dynamics ....................................................................................... 146
6.1.3.1 Impact Analysis................................................................................................ 147

6.1.4 Sizing and Forecast Analysis ................................................................... 147

6.1.4.1 North America Digital Biomarkers Market (by Application) .............................. 148

6.1.4.2 North America Digital Biomarkers Market (by Type) ....................................... 149

All rights reserved at BIS Research Inc. 7

 6.1.5 North America Digital Biomarkers Market (by Country) ........................ 150
6.1.5.1 U.S. .................................................................................................................. 150

6.1.5.1.1 Digital Health Scenario .......................................................................................... 150

6.1.5.1.2 Degree of Adoption of Wearables .......................................................................... 150

6.1.5.1.3 Degree of Adoption of Mobile Health Applications ................................................ 151

6.1.5.1.4 Local Players in the Digital Biomarker Market ....................................................... 151

6.1.5.1.5 U.S. Digital Biomarkers Market .............................................................................. 151

6.1.5.1.6 U.S. Digital Biomarkers Market (by Type) ............................................................. 152

6.1.5.1.7 U.S. Digital Biomarkers Market (by Application) .................................................... 153

6.1.5.2 Canada ............................................................................................................ 153

6.1.5.2.1 Digital Health Scenario .......................................................................................... 153

6.1.5.2.2 Degree of Adoption of Wearables .......................................................................... 154

6.1.5.2.3 Degree of Adoption of Mobile Health Applications ................................................ 154

6.1.5.2.4 Local Players in the Digital Biomarker Market ....................................................... 155

6.1.5.2.5 Canada Digital Biomarkers Market ........................................................................ 155

6.1.5.2.6 Canada Digital Biomarkers Market (by Type) ........................................................ 156

6.1.5.2.7 Canada Digital Biomarkers Market (by Application) .............................................. 156

6.2 Europe Digital Biomarkers Market ............................................................... 157

6.2.1 Regulatory Framework.............................................................................. 157
6.2.2 Opportunity Assessment .......................................................................... 158
6.2.3 Market Dynamics ....................................................................................... 159
6.2.3.1 Impact Analysis................................................................................................ 160

6.2.4 Sizing and Forecast Analysis ................................................................... 160

6.2.4.1 Europe Digital Biomarkers Market (by Application) ......................................... 161

6.2.4.2 Europe Digital Biomarkers Market (by Type) ................................................... 162

6.2.5 Europe Digital Biomarkers Market (by Country) ..................................... 163

6.2.5.1 Netherlands ..................................................................................................... 163

6.2.5.1.1 Digital Health Scenario .......................................................................................... 163

6.2.5.1.2 Degree of Adoption of Wearables .......................................................................... 163

6.2.5.1.3 Degree of Adoption of Mobile Health Applications ................................................ 163

All rights reserved at BIS Research Inc. 8

 6.2.5.1.4 Local Players in the Digital Biomarker Market ....................................................... 164

6.2.5.1.5 Netherlands Digital Biomarkers Market ................................................................. 164

6.2.5.1.6 Netherlands Digital Biomarkers Market (by Type) ................................................. 165

6.2.5.1.7 Netherlands Digital Biomarkers Market (by Application) ....................................... 165

6.2.5.2 Germany .......................................................................................................... 166

6.2.5.2.1 Digital Health Scenario .......................................................................................... 166

6.2.5.2.2 Degree of Adoption of Wearables .......................................................................... 166

6.2.5.2.3 Reluctance to Fitness Trackers ............................................................................. 167

6.2.5.2.4 Future of Digital Health in Germany....................................................................... 167

6.2.5.2.5 Germany Digital Biomarkers Market ...................................................................... 168

6.2.5.2.6 Germany Digital Biomarkers Market (by Type)...................................................... 168

6.2.5.2.7 Germany Digital Biomarkers Market (by Application) ............................................ 169

6.2.5.3 France.............................................................................................................. 170

6.2.5.3.1 Digital Health Scenario .......................................................................................... 170

6.2.5.3.2 Degree of Adoption of Wearables .......................................................................... 170

6.2.5.3.3 Local Players in Digital Biomarkers Market ........................................................... 170

6.2.5.3.4 France Digital Biomarkers Market.......................................................................... 171

6.2.5.3.5 France Digital Biomarkers Market (by Type) ......................................................... 171

6.2.5.3.6 France Digital Biomarkers Market (by Application)................................................ 172

6.2.5.4 Italy .................................................................................................................. 173

6.2.5.4.1 Digital Health Scenario .......................................................................................... 173

6.2.5.4.2 Degree of Adoption of Wearables .......................................................................... 173

6.2.5.4.3 Italy Digital Biomarkers Market .............................................................................. 174

6.2.5.4.4 Italy Digital Biomarkers Market (by Type) .............................................................. 174

6.2.5.4.5 Italy Digital Biomarkers Market (by Application) .................................................... 175

6.2.5.5 Spain................................................................................................................ 176

6.2.5.5.1 Digital Health Scenario .......................................................................................... 176

6.2.5.5.2 Degree of Adoption of Wearables .......................................................................... 176

6.2.5.5.3 Spain Digital Biomarkers Market............................................................................ 176

6.2.5.5.4 Spain Digital Biomarkers Market (by Type) ........................................................... 177

All rights reserved at BIS Research Inc. 9

 6.2.5.5.5 Spain Digital Biomarkers Market (by Application).................................................. 178

6.2.5.6 Russia .............................................................................................................. 178

6.2.5.6.1 Digital Health Scenario .......................................................................................... 178

6.2.5.6.2 Degree of Adoption of Wearables .......................................................................... 179

6.2.5.6.3 Degree of Adoption of Mobile Health Applications ................................................ 179

6.2.5.6.4 Russia Digital Biomarkers Market .......................................................................... 179

6.2.5.6.5 Russia Digital Biomarkers Market (by Type) ......................................................... 180

6.2.5.6.6 Russia Digital Biomarkers Market (by Application) ................................................ 181

6.2.5.7 U.K. .................................................................................................................. 181

6.2.5.7.1 Digital Health Scenario .......................................................................................... 181

6.2.5.7.2 Degree of Adoption of Wearables .......................................................................... 182

6.2.5.7.3 Increasing Sales of Smartwatches......................................................................... 182

6.2.5.7.4 Abandonment of Wearables .................................................................................. 182

6.2.5.7.5 Local Players in Digital Biomarkers ....................................................................... 182

6.2.5.7.6 U.K. Digital Biomarkers Market .............................................................................. 183

6.2.5.7.7 U.K. Digital Biomarkers Market (by Type) ............................................................. 183

6.2.5.7.8 U.K. Digital Biomarkers Market (by Application) .................................................... 184

6.2.5.8 Rest-of-Europe ................................................................................................ 185

6.2.5.8.1 Digital Health Scenario .......................................................................................... 185

6.2.5.8.2 Degree of Adoption of Wearables .......................................................................... 185

6.2.5.8.3 Increasing Sales of Smartwatches......................................................................... 185

6.2.5.8.4 Local Players in Digital Biomarkers ....................................................................... 186

6.2.5.8.5 Rest-of-Europe Digital Biomarkers Market ............................................................ 186

6.2.5.8.6 Rest-of-Europe Digital Biomarkers Market (by Type) ............................................ 186

6.2.5.8.7 Rest-of-Europe Digital Biomarkers Market (by Application) .................................. 187

6.3 Asia-Pacific Digital Biomarkers Market ....................................................... 188

6.3.1 Regulatory Framework.............................................................................. 188
6.3.2 Opportunity Assessment .......................................................................... 189
6.3.3 Market Dynamics ....................................................................................... 190
6.3.3.1 Impact Analysis................................................................................................ 190

All rights reserved at BIS Research Inc. 10

 6.3.4 Sizing and Forecast Analysis ................................................................... 191
6.3.4.1 Asia-Pacific Digital Biomarkers Market (by Application) .................................. 191

6.3.4.2 Asia-Pacific Digital Biomarkers Market (by Type) ............................................ 192

6.3.5 Asia-Pacific Digital Biomarkers Market (by Country) ............................. 193

6.3.5.1 Singapore ........................................................................................................ 193

6.3.5.1.1 Digital Health Scenario .......................................................................................... 193

6.3.5.1.2 Degree of Adoption of Wearables .......................................................................... 193

6.3.5.1.3 Degree of Adoption of Mobile Health ..................................................................... 193

6.3.5.1.4 Singapore Digital Biomarkers Market .................................................................... 193

6.3.5.1.5 Singapore Digital Biomarkers Market (by Type) .................................................... 194

6.3.5.1.6 Singapore Digital Biomarkers Market (by Application) .......................................... 195

6.3.5.2 Australia ........................................................................................................... 195

6.3.5.2.1 Digital Health Scenario .......................................................................................... 195

6.3.5.2.2 Degree of Adoption of Wearables .......................................................................... 196

6.3.5.2.3 Degree of Adoption of Mobile Health ..................................................................... 196

6.3.5.2.4 Australia Digital Biomarkers Market ....................................................................... 197

6.3.5.2.5 Australia Digital Biomarkers Market (by Type) ...................................................... 197

6.3.5.2.6 Australia Digital Biomarkers Market (by Application) ............................................. 198

6.3.5.3 India ................................................................................................................. 199

6.3.5.3.1 Digital Health Scenario .......................................................................................... 199

6.3.5.3.2 Degree of Adoption of Wearables .......................................................................... 199

6.3.5.3.3 Degree of Adoption of Mobile Health ..................................................................... 200

6.3.5.3.4 India Digital Biomarkers Market ............................................................................. 200

6.3.5.3.5 India Digital Biomarkers Market (by Type) ............................................................. 201

6.3.5.3.6 India Digital Biomarkers Market (by Application) ................................................... 202

6.3.5.4 South Korea ..................................................................................................... 202

6.3.5.4.1 Digital Health Scenario .......................................................................................... 202

6.3.5.4.2 Degree of Adoption of Wearables .......................................................................... 203

6.3.5.4.3 Degree of Adoption of Mobile Health ..................................................................... 203

6.3.5.4.4 South Korea Digital Biomarkers Market ................................................................. 203

All rights reserved at BIS Research Inc. 11

 6.3.5.4.5 South Korea Digital Biomarkers Market (by Type) ................................................ 204

6.3.5.4.6 South Korea Digital Biomarkers Market (by Application) ....................................... 205

6.3.5.5 Japan ............................................................................................................... 205

6.3.5.5.1 Digital Health Scenario .......................................................................................... 205

6.3.5.5.2 Degree of Adoption of Wearables .......................................................................... 206

6.3.5.5.3 Degree of Adoption of Mobile Health ..................................................................... 206

6.3.5.5.4 Japan Digital Biomarkers Market ........................................................................... 206

6.3.5.5.5 Japan Digital Biomarkers Market (by Type) ........................................................... 207

6.3.5.5.6 Japan Digital Biomarkers Market (by Application) ................................................. 208

6.3.5.6 China ............................................................................................................... 208

6.3.5.6.1 Digital Health Scenario .......................................................................................... 208

6.3.5.6.2 Degree of Adoption of Wearables .......................................................................... 209

6.3.5.6.3 Degree of Adoption of Mobile Health ..................................................................... 209

6.3.5.6.4 Local Players in Digital Biomarker Market ............................................................. 210

6.3.5.6.5 China Digital Biomarkers Market ........................................................................... 210

6.3.5.6.6 China Digital Biomarkers Market (by Type) ........................................................... 211

6.3.5.6.7 China Digital Biomarkers Market (by Application) ................................................. 211

6.3.5.7 Rest-of-Asia-Pacific ......................................................................................... 212

6.3.5.7.1 Digital Health Scenario .......................................................................................... 212

6.3.5.7.2 Degree of Adoption of Wearables .......................................................................... 212

6.3.5.7.3 Degree of Adoption of Mobile Health Applications ................................................ 213

6.3.5.7.4 Rest-of-Asia-Pacific Digital Biomarkers Market ..................................................... 213

6.3.5.7.5 Rest-of-Asia-Pacific Digital Biomarkers Market (by Type) ..................................... 214

6.3.5.7.6 Rest-of-Asia-Pacific Digital Biomarkers Market (by Application) ........................... 214

6.4 Latin America Digital Biomarkers Market .................................................... 215

6.4.1 Regulatory Framework.............................................................................. 215
6.4.2 Opportunity Assessment .......................................................................... 216
6.4.3 Market Dynamics ....................................................................................... 216
6.4.3.1 Impact Analysis................................................................................................ 217

6.4.4 Sizing and Forecast Analysis ................................................................... 217

All rights reserved at BIS Research Inc. 12

 6.4.4.1 Latin America Digital Biomarkers Market (by Application) ............................... 218

6.4.4.2 Latin America Digital Biomarkers Market (by Type) ........................................ 219

6.4.5 Latin America Digital Biomarkers Market (by Country) ......................... 220
6.4.5.1 Brazil ................................................................................................................ 220

6.4.5.1.1 Digital Health Scenario .......................................................................................... 220

6.4.5.1.2 Degree of Adoption of Mobile Health Applications ................................................ 220

6.4.5.1.3 Brazil Digital Biomarkers Market ............................................................................ 221

6.4.5.1.4 Brazil Digital Biomarkers Market (by Type) ........................................................... 221

6.4.5.1.5 Brazil Digital Biomarkers Market (by Application) .................................................. 222

6.4.5.2 Mexico ............................................................................................................. 223

6.4.5.2.1 Digital Health Scenario .......................................................................................... 223

6.4.5.2.2 Degree of Adoption of Mobile Health Applications ................................................ 223

6.4.5.2.3 Mexico Digital Biomarkers Market ......................................................................... 224

6.4.5.2.4 Mexico Digital Biomarkers Market (by Type) ......................................................... 224

6.4.5.2.5 Mexico Digital Biomarkers Market (by Application) ............................................... 225

6.4.5.3 Rest-of-Latin America ...................................................................................... 226

6.4.5.3.1 Digital Health Scenario .......................................................................................... 226

6.4.5.3.2 Degree of Adoption of Wearables .......................................................................... 226

6.4.5.3.3 Degree of Adoption of Mobile Health ..................................................................... 226

6.4.5.3.4 Rest-of-Latin America Digital Biomarkers Market .................................................. 227

6.4.5.3.5 Rest-of-Latin America Digital Biomarkers Market (by Type) ................................. 228

6.4.5.3.6 Rest-of-Latin America Digital Biomarkers Market (by Application) ........................ 228

6.5 Rest-of-the-World .......................................................................................... 229

6.5.1 Regulatory Framework.............................................................................. 229
6.5.2 Opportunity Assessment .......................................................................... 230
6.5.3 Market Dynamics ....................................................................................... 230
6.5.3.1 Impact Analysis................................................................................................ 231

6.5.4 Sizing and Forecast Analysis ................................................................... 231

6.5.4.1 Rest-of-the-World Digital Biomarkers Market (by Application) ........................ 232

6.5.4.2 Rest-of-the-World Digital Biomarkers Market (by Type) .................................. 233

All rights reserved at BIS Research Inc. 13

 6.5.5 Rest-of-the-World Digital Biomarkers Market (by Country) ................... 234
6.5.5.1 Saudi Arabia .................................................................................................... 234

6.5.5.1.1 Digital Health Scenario .......................................................................................... 234

6.5.5.1.2 Degree of Adoption of Wearables .......................................................................... 234

6.5.5.1.3 Degree of Adoption of Mobile Health Applications ................................................ 234

6.5.5.1.4 Saudi Arabia Digital Biomarkers Market ................................................................ 235

6.5.5.1.5 Saudi Arabia Digital Biomarkers Market (by Type) ................................................ 235

6.5.5.1.6 Saudi Arabia Digital Biomarkers Market (by Application) ...................................... 236

6.5.5.2 U.A.E ............................................................................................................... 237

6.5.5.2.1 Digital Health Scenario .......................................................................................... 237

6.5.5.2.2 Degree of Adoption of Wearables .......................................................................... 237

6.5.5.2.3 Degree of Adoption of Mobile Health Applications ................................................ 237

6.5.5.2.4 U.A.E. Digital Biomarkers Market .......................................................................... 237

6.5.5.2.5 U.A.E. Digital Biomarkers Market (by Type) .......................................................... 238

6.5.5.2.6 U.A.E. Digital Biomarkers Market (by Application) ................................................ 239

6.5.5.3 Israel ................................................................................................................ 239

6.5.5.3.1 Digital Health Scenario .......................................................................................... 239

6.5.5.3.2 Degree of Adoption of Wearables .......................................................................... 240

6.5.5.3.3 Degree of Adoption of Mobile Health Applications ................................................ 240

6.5.5.3.4 Israel Digital Biomarkers Market ............................................................................ 240

6.5.5.3.5 Israel Digital Biomarkers Market (by Type) ............................................................ 241

6.5.5.3.6 Israel Digital Biomarkers Market (by Application) .................................................. 241

6.5.5.4 South Africa ..................................................................................................... 242

6.5.5.4.1 Digital Health Scenario .......................................................................................... 242

6.5.5.4.2 Degree of Adoption of Wearables .......................................................................... 242

6.5.5.4.3 Degree of Adoption of Mobile Health Applications ................................................ 243

6.5.5.4.4 South Africa Digital Biomarkers Market ................................................................. 243

6.5.5.4.5 South Africa Digital Biomarkers Market (by Type) ................................................. 244

6.5.5.4.6 South Africa Digital Biomarkers Market (by Application) ....................................... 244

6.5.5.5 Rest-of-Rest-of-the-World................................................................................ 245

All rights reserved at BIS Research Inc. 14

 6.5.5.5.1 Digital Health Scenario .......................................................................................... 245

6.5.5.5.2 Degree of Adoption of Wearables .......................................................................... 245

6.5.5.5.3 Degree of Adoption of Mobile Health Applications ................................................ 245

6.5.5.5.4 Rest-of-Rest-of -the-World Digital Biomarkers Market .......................................... 246

6.5.5.5.5 Rest-of-Rest-of-the-World Digital Biomarkers Market (by Type) ........................... 247

6.5.5.5.6 Rest-of-Rest-of-the-World Digital Biomarkers Market (by Application) ................. 247

7. Market- Company Profiles and Competitive Benchmarking .........249

7.1 Competitive Landscape ................................................................................ 249
7.1.1 Key Strategies and Developments ........................................................... 249
7.1.1.1 Partnerships, Alliances, and Business Expansions ......................................... 250

7.1.1.2 Funding Activities............................................................................................. 251

7.1.1.2.1 New Offerings ........................................................................................................ 251

7.1.1.2.2 Mergers and Acquisitions ....................................................................................... 252

7.1.1.2.3 Regulatory and Legal Activities.............................................................................. 253

7.2 Company Profiles .......................................................................................... 254

7.2.1 Established Companies ............................................................................ 254
7.2.1.1 Alphabet Inc. .................................................................................................... 254

7.2.1.1.1 Company Overview ................................................................................................ 254

7.2.1.1.2 Role of Alphabet Inc. in the Global Digital Biomarkers Market .............................. 254

7.2.1.1.3 Product Portfolio and Offerings .............................................................................. 255

7.2.1.1.4 Financials ............................................................................................................... 256

7.2.1.1.4.1 Recent Developments .................................................................................... 257

7.2.1.1.5 SWOT Analysis ...................................................................................................... 259

7.2.1.2 AliveCor Inc. .................................................................................................... 260

7.2.1.2.1 Company Overview ................................................................................................ 260

7.2.1.2.2 Role of AliveCor, Inc. in the Global Digital Biomarkers Market ............................. 260

7.2.1.2.3 Product Portfolio and Offerings .............................................................................. 260

7.2.1.2.4 Recent Development ............................................................................................. 261

7.2.1.2.5 SWOT Analysis ...................................................................................................... 262

7.2.1.3 Akili Interactive Labs, Inc. ................................................................................ 263

All rights reserved at BIS Research Inc. 15

 7.2.1.3.1 Company Overview ................................................................................................ 263

7.2.1.3.2 Role of Akili Interactive Labs in the Global Digital Biomarkers Market .................. 263

7.2.1.3.3 Product Portfolio and Offerings .............................................................................. 263

7.2.1.3.3.1.1 Recent Developments ........................................................................................... 264

7.2.1.3.3.1.2 SWOT Analysis ..................................................................................................... 264

7.2.1.4 Cambridge Cognition Ltd ................................................................................. 265

7.2.1.4.1 Company Overview ................................................................................................ 265

7.2.1.4.2 Role of Cambridge Cognition Ltd in the Global Digital Biomarkers Market ........... 265

7.2.1.4.3 Product Portfolio and Offerings .............................................................................. 265

7.2.1.4.4 Financials ............................................................................................................... 266

7.2.1.4.5 Recent Developments ............................................................................................ 268

7.2.1.4.6 SWOT Analysis ...................................................................................................... 269

7.2.1.5 Dassault Systèmes .......................................................................................... 270

7.2.1.5.1 Company Overview ................................................................................................ 270

7.2.1.5.2 Role of Dassault Systèmes in the Global Digital Biomarkers Market .................... 270

7.2.1.5.3 Product Portfolio and Offerings .............................................................................. 271

7.2.1.5.4 Financials ............................................................................................................... 272

7.2.1.5.5 Recent Developments ............................................................................................ 274

7.2.1.5.6 SWOT Analysis ...................................................................................................... 274

7.2.1.6 IXICO plc ......................................................................................................... 276

7.2.1.6.1 Company Overview ................................................................................................ 276

7.2.1.6.2 Role of IXICO plc in the Global Digital Biomarkers Market ................................... 276

7.2.1.6.3 Product Portfolio and Offerings .............................................................................. 277

7.2.1.6.4 Financials ............................................................................................................... 278

7.2.1.6.5 Recent Developments ............................................................................................ 279

7.2.1.6.6 SWOT Analysis ...................................................................................................... 280

7.2.1.7 Koninklijke Philips N.V. .................................................................................... 281

7.2.1.7.1 Company Overview ................................................................................................ 281

7.2.1.7.2 Role of Koninklijke Philips N.V. in the Global Digital Biomarkers Market .............. 281

7.2.1.7.3 Product Portfolio and Offerings .............................................................................. 281

All rights reserved at BIS Research Inc. 16

 7.2.1.7.4 Financials ............................................................................................................... 282

7.2.1.7.4.1 Koninklijke Philips N.V.: SWOT Analysis........................................................ 284

7.2.1.8 Shimmer .......................................................................................................... 286

7.2.1.8.1 Company Overview ................................................................................................ 286

7.2.1.8.2 Role of Shimmer in the Global Digital Biomarkers Market .................................... 286

7.2.1.8.3 Product Portfolio and Offerings .............................................................................. 287

7.2.1.8.3.1 Recent Developments .................................................................................... 287

7.2.1.8.4 SWOT Analysis ...................................................................................................... 288

7.2.1.9 Quanterix Corporation ..................................................................................... 289

7.2.1.9.1 Company Overview ................................................................................................ 289

7.2.1.9.2 Role of Quanterix Corporation in the Global Digital Biomarkers Market ............... 289

7.2.1.9.3 Product Portfolio and Offerings .............................................................................. 289

7.2.1.9.4 Financials ............................................................................................................... 290

7.2.1.9.5 Recent Developments ............................................................................................ 292

7.2.1.9.6 SWOT Analysis ...................................................................................................... 292

7.2.2 Start-Ups .................................................................................................... 294

7.2.2.1 Altoida AG........................................................................................................ 294

7.2.2.1.1 Company Overview ................................................................................................ 294

7.2.2.1.2 Role of Altoida AG in the Global Digital Biomarkers Market .................................. 294

7.2.2.1.3 Product Portfolio and Offerings .............................................................................. 294

7.2.2.1.4 Recent Developments ............................................................................................ 295

7.2.2.1.5 SWOT Analysis ...................................................................................................... 295

7.2.2.2 Evidation Health, Inc. ....................................................................................... 296

7.2.2.2.1 Company Overview ................................................................................................ 296

7.2.2.2.2 Role of Evidation Health, Inc. in the Global Digital Biomarker Market................... 296

7.2.2.2.3 Product Portfolio and Offerings .............................................................................. 296

7.2.2.2.4 Recent Developments ............................................................................................ 297

7.2.2.2.5 SWOT Analysis ...................................................................................................... 297

7.2.2.3 Happify, Inc. ..................................................................................................... 298

7.2.2.3.1 Company Overview ................................................................................................ 298

All rights reserved at BIS Research Inc. 17

 7.2.2.3.2 Role of Happify, Inc. in the Global Digital Biomarker Market ................................. 298

7.2.2.3.3 Product Portfolio and Offerings .............................................................................. 298

7.2.2.3.4 Recent Developments ............................................................................................ 299

7.2.2.3.5 SWOT Analysis ...................................................................................................... 299

7.2.2.4 Huma ............................................................................................................... 300

7.2.2.4.1 Company Overview ................................................................................................ 300

7.2.2.4.2 Role of Huma in the Global Digital Biomarker Market ........................................... 300

7.2.2.4.3 Product Portfolio and Offerings .............................................................................. 300

7.2.2.4.4 Recent Developments ............................................................................................ 301

7.2.2.4.5 SWOT Analysis ...................................................................................................... 301

7.2.2.5 Human API ...................................................................................................... 302

7.2.2.5.1 Company Overview ................................................................................................ 302

7.2.2.5.2 Role of Human API in the Global Digital Biomarkers Market. ............................... 302

7.2.2.5.3 Product Portfolio and Offerings .............................................................................. 302

7.2.2.5.4 Recent Developments ............................................................................................ 303

7.2.2.5.5 SWOT Analysis ...................................................................................................... 303

7.2.2.6 Mindstrong Health............................................................................................ 304

7.2.2.6.1 Company Overview ................................................................................................ 304

7.2.2.6.2 Role of Mindstrong Health in the Global Digital Biomarker Market ....................... 304

7.2.2.6.3 Product Portfolio and Offerings .............................................................................. 304

7.2.2.6.4 Recent Developments ............................................................................................ 305

7.2.2.6.5 SWOT Analysis ...................................................................................................... 305

7.2.2.7 Neurotrack Technologies, Inc. ......................................................................... 306

7.2.2.7.1 Company Overview ................................................................................................ 306

7.2.2.7.2 Role of Neurotrack Technologies, Inc. in the Global Digital Biomarker

Market ................................................................................................................... 306

7.2.2.7.3 Product Portfolio and Offerings .............................................................................. 306

7.2.2.7.4 Recent Developments ............................................................................................ 307

7.2.2.7.5 SWOT Analysis ...................................................................................................... 307

7.2.2.8 Orikami ............................................................................................................ 308

All rights reserved at BIS Research Inc. 18

 7.2.2.8.1 Company Overview ................................................................................................ 308

7.2.2.8.2 Role of Orikami in the Global Digital Biomarker Market ........................................ 308

7.2.2.8.3 Product Portfolio and Offerings .............................................................................. 308

7.2.2.8.4 Recent Developments ............................................................................................ 309

7.2.2.8.5 SWOT Analysis ...................................................................................................... 309

7.2.2.9 Winterlight Labs Inc. ........................................................................................ 310

7.2.2.9.1 Company Overview ................................................................................................ 310

7.2.2.9.2 Role of Winterlight Labs, Inc. in the Global Digital Biomarkers Market ................. 310

7.2.2.9.3 Product Portfolio and Offerings .............................................................................. 310

7.2.2.9.4 Recent Developments ............................................................................................ 311

7.2.2.9.5 SWOT Analysis ...................................................................................................... 311

All rights reserved at BIS Research Inc. 19

List of Figures
Figure 1: Evolution of Digital Health

Figure 2: Applications of Digital Biomarkers

Figure 3: Global Digital Biomarkers Market, Impact Analysis

Figure 4: Global Digital Biomarkers Market Potential, $Million, 2020, 2024, and 2028

Figure 5: Global Digital Biomarkers Market (by System Components), $Million, 2021,2024 and 2028

Figure 6: Global Digital Biomarkers Market (by End User), $Million, 2019-2028

Figure 7: Global Digital Biomarker Market, Key Developments and Strategies, January 2017-December
2021

Figure 8: Growth-Share Matrix of the Global Digital Biomarkers Market, 2021-2028

Figure 9: Global Digital Biomarkers Market Segmentation

Figure 10: Global Digital Biomarkers Market: Research Methodology

Figure 11: Primary Research

Figure 12: Secondary Research

Figure 13: Data Triangulation

Figure 14: Global Digital Biomarkers Market Research Process

Figure 15: Assumptions and Limitations

Figure 16: Global Digital Biomarkers Market, Realistic Growth Scenario, $Million, 2019-2028

Figure 17: Global Digital Biomarkers Market, Optimistic Growth Scenario, $Million, 2019-2028

Figure 18: Global Digital Biomarkers Market, Pessimistic Growth Scenario, $Million, 2019-2028

Figure 19: Digital Biomarkers Ecosystem

Figure 20: Workflow of Digital Health Tools

Figure 21: Global Digital Biomarkers Market, Short-Term Growth Potential, $Million, 2022-2025

Figure 22: Global Digital Biomarkers Market, Long-Term Growth Potential, $Million, 2026-2028

Figure 23: Global Digital Biomarkers Market, Product Benchmarking

Figure 24: Global Digital Biomarkers Market, Patent Publication Growth Trend, January 2019-December
2021

Figure 25: Global Digital Biomarkers Market, Patent Filing Trend (by Country/Cluster), January 2019-
December 2021

Figure 26: Applications of Wearables in COVID-19

Figure 27: Digital Biomarkers and COVID-19 Pandemic

Figure 28: Global Digital Biomarkers Market Pre-COVID-19 Scenario, $Million, 2020-2028

All rights reserved at BIS Research Inc. 20

Figure 29: Global Digital Biomarkers Market Y-o-Y Growth Comparative Analysis (With COVID-19 Vs.
Without COVID-19)

Figure 30: Impact Trends and Scenarios During COVID-19 (by Region), 2020-2021

Figure 31: Global Digital Biomarkers Market, Impact Analysis

Figure 32: Process of Transmission of Data in Digital Biomarkers

Figure 33: Healthcare Interoperability Challenges

Figure 34: Global Digital Biomarkers Market (by Application)

Figure 35: Global Digital Biomarkers Market Incremental Opportunity (by Application), $Million, 2022-
2028

Figure 36: Global Digital Biomarkers Market, Growth-Share Matrix (by Application), 2021-2028

Figure 37: Global Digital Biomarkers Market (Gastrointestinal Diseases), $Million, 2019-2028

Figure 38: Global Digital Biomarkers Market (Sleep and Movement Disorders), $Million, 2019-2028

Figure 39: Global Digital Biomarkers Market (Cardiovascular), $Million, 2019-2028

Figure 40: Global Digital Biomarkers Market (Psychiatric Disorders (Mood and Behavior)), $Million, 2019-
2028

Figure 41: Global Digital Biomarkers Market (Chronic Pain), $Million, 2019-2028

Figure 42: Global Digital Biomarkers Market (Neurodegenerative Disorders), $Million, 2019-2028

Figure 43: Global Digital Biomarkers Market (Diabetes), $Million, 2019-2028

Figure 44: Global Digital Biomarkers Market (Respiratory Diseases), $Million, 2019-2028

Figure 45: Global Digital Biomarkers Market (Others), $Million, 2019-2028

Figure 46: Global Digital Biomarkers Market (by End User)

Figure 47: Global Digital Biomarkers Market Incremental Opportunity (by End User), $Million, 2022-2028

Figure 48: Global Digital Biomarkers Market, Growth-Share Matrix (by End User), 2021e-2028

Figure 49: Global Digital Biomarkers Market (Biopharmaceutical Companies), $Million, 2019-2028

Figure 50: Global Digital Biomarkers Market (Payers), $Million, 2019-2028

Figure 51: Global Digital Biomarkers Market (Providers), $Million, 2019-2028

Figure 52: Global Digital Biomarkers Market (by System Components)

Figure 53: Global Digital Biomarkers Market Incremental Opportunity (by Product Type), $Million, 2022-
2028

Figure 54: Market Share Analysis (by System Components), $Million, 2021

Figure 55: Global Digital Biomarkers Market, Growth-Share Matrix (by System Components), 2021-2028

Figure 56: Global Digital Biomarker Data Collection Tools Market, $Million, 2019-2028

Figure 57: Applications of Healthcare Wearables

Figure 58: Number of Clinical Trials Using Connected Wearable Devices (by Year) (Cumulative)
All rights reserved at BIS Research Inc. 21
Figure 59: Global Digital Biomarkers Market (Wearable Devices), $Million, 2019-2028

Figure 60: Global Digital Biomarkers Market (Implantables), $Million, 2019-2028

Figure 61: Benefits of mHealth

Figure 62: Global Digital Biomarkers Market (Mobile Applications), $Million, 2019-2028

Figure 63: Process of Data Integration in Remote Patient Monitoring (RPM)

Figure 64: Global Digital Biomarkers Market (Data Integration Software), $Million, 2019-2028

Figure 65: Global Digital Biomarkers Market (by Type)

Figure 66: Global Digital Biomarkers Market Incremental Opportunity (by Type), $Million, 2022-2028

Figure 67: Market Share Analysis (by System Components), $Million, 2021

Figure 68: Global Digital Biomarkers Market, Growth-Share Matrix (by Type), 2021-2028

Figure 69: Global Digital Biomarkers Market (Clinical Trials), $Million, 2019-2028

Figure 70: Global Digital Biomarkers Market (Clinical Settings), $Million, 2019-2028

Figure 71: North America Digital Biomarkers Market Incremental Growth Opportunity (by Country),
$Million, 2022-2028

Figure 72: North America Digital Biomarkers Market, $Million, 2019-2028

Figure 73: North America Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 74: North America Digital Biomarkers Market (By Type), $Million, 2019-2028

Figure 75: U.S. Digital Biomarkers Market, $Million, 2019-2028

Figure 76: U.S. Digital Biomarkers Market (by Product Type), $Million, 2019-2028

Figure 77: U.S. Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 78: Canada Digital Biomarkers Market, $Million, 2019-2028

Figure 79: Canada Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 80: Canada Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 81: Europe Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million,
2022-2028

Figure 82: Europe Digital Biomarkers Market, $Million, 2019-2028

Figure 83: Europe Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 84: Europe Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 85: Netherlands Digital Biomarkers Market, $Million, 2019-2028

Figure 86: Netherlands Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 87: Netherlands Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 88: Germany Digital Biomarkers Market, $Million, 2019-2028

Figure 89: Germany Digital Biomarkers Market (by Type), $Million, 2019-2028

All rights reserved at BIS Research Inc. 22

Figure 90: Germany Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 91: France Digital Biomarkers Market, $Million, 2019-2028

Figure 92: France Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 93: France Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 94: Italy Digital Biomarkers Market, $Million, 2019-2028

Figure 95: Italy Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 96: Italy Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 97: Spain Digital Biomarkers Market, $Million, 2019-2028

Figure 98: Spain Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 99: Spain Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 100: Russia Digital Biomarkers Market, $Million, 2019-2028

Figure 101: Russia Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 102: Russia Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 103: U.K. Digital Biomarkers Market, $Million, 2019-2028

Figure 104: U.K. Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 105: U.K. Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 106: Rest-of-Europe Digital Biomarkers Market, $Million, 2019-2028

Figure 107: Rest-of-Europe Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 108: Rest-of-Europe Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 109: Asia-Pacific Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million,
2022-2028

Figure 110: Asia-Pacific Digital Biomarkers Market, $Million, 2019-2028

Figure 111: Asia-Pacific Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 112: Asia-Pacific Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 113: Singapore Digital Biomarkers Market, $Million, 2019-2028

Figure 114: Singapore Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 115: Singapore Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 116: Australia Digital Biomarkers Market, $Million, 2019-2028

Figure 117: Australia Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 118: Australia Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 119: India Digital Biomarkers Market, $Million, 2019-2028

Figure 120: India Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 121: India Digital Biomarkers Market (by Application), $Million, 2019-2028

All rights reserved at BIS Research Inc. 23

Figure 122: South Korea Digital Biomarkers Market, $Million, 2019-2028

Figure 123: South Korea Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 124: South Korea Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 125: Japan Digital Biomarkers market, $Million, 2019-2028

Figure 126: Japan Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 127: Japan Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 128: China Digital Biomarkers Market, $Million, 2019-2028

Figure 129: China Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 130: China Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 131: Rest-of-Asia-Pacific Digital Biomarkers Market, $Million, 2019-2028

Figure 132: Rest-of-Asia-Pacific Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 133: Rest-of-Asia-Pacific Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 134: Latin America Digital Biomarkers Market Incremental Growth Opportunity (by Country),
$Million, 2022-2028

Figure 135: Latin America Digital Biomarkers Market, $Million, 2019-2028

Figure 136: Latin America Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 137: Latin America Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 138: Brazil Digital Biomarkers Market, $Million, 2019-2028

Figure 139: Brazil Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 140: Brazil Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 141: Mexico Digital Biomarkers Market, $Million, 2019-2028

Figure 142: Mexico Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 143: Mexico Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 144: Rest-of-Latin America Digital Biomarkers Market, $Million, 2019-2028

Figure 145: Rest-of-Latin America Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 146: Rest-of-Latin America Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 147: Rest-of-the-World Digital Biomarkers Market Regulations

Figure 148: Rest-of-the-World Digital Biomarkers Market Incremental Growth Opportunity (by Country),
$Million, 2022-2028

Figure 149: Rest-of-the-World Digital Biomarkers market, $Million, 2019-2028

Figure 150: Rest-of-the-World Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 151: Rest-of-the-World Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 152: Saudi Arabia Digital Biomarkers Market, $Million, 2019-2028

All rights reserved at BIS Research Inc. 24

Figure 153: Saudi Arabia Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 154: Saudi Arabia Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 155: U.A.E. Digital Biomarkers Market, $Million, 2019-2028

Figure 156: U.A.E. Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 157: U.A.E. Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 158: Israel Digital Biomarkers Market, $Million, 2019-2028

Figure 159: Israel Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 160: Israel Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 161: South Africa Digital Biomarkers Market, $Million, 2019-2028

Figure 162: South Africa Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 163: South Africa Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 164: Rest-of-Rest-of-the-World Digital Biomarkers Market, $Million, 2019-2028

Figure 165: Rest-of-Rest-of-the-World Digital Biomarkers Market (by Type), $Million, 2019-2028

Figure 166: Rest-of-Rest-of-the-World Digital Biomarkers Market (by Application), $Million, 2019-2028

Figure 167: Global Digital Biomarkers Market, Key Developments, January 2017-February 2022

Figure 168: Partnerships, Alliances, and Business Expansions Share (by Company), January 2017-
February 2022

Figure 169: Funding Activities (by Company), January 2017-February 2022

Figure 170: New Product Offerings and Upgradations Share (by Company), January 2017-February 2022

Figure 171: Mergers and Acquisitions (by Company), January 2017-February 2022

Figure 172: Regulatory and Legal Activities Share (by Company), January 2017-February 2022

Figure 173: Alphabet Inc.: Overall Product Portfolio

Figure 174: Alphabet Inc.: Overall Financials, $Million, 2019-2021

Figure 175: Alphabet Inc.: R&D Expenditure, $Million, 2019-2021

Figure 176: Alphabet Inc.: Revenue (by Region), $Million, 2019-2021

Figure 177: AliveCor, Inc: Overall Product Portfolio

Figure 178: Akili Interactive Labs: Overall Product Portfolio

Figure 179: Cambridge Cognition Ltd.: Overall Product Portfolio

Figure 180: Cambridge Cognition Ltd: Overall Financials, $Million, 2018-2020

Figure 181: Cambridge Cognition Ltd: Net Revenue (by Segment), $Million, 2018-2020

Figure 182: Cambridge Cognition Ltd: Net Revenue (by Region), $Million, 2018-2020

Figure 183: Cambridge Cognition Ltd: R&D Expenditure, $Million, 2018-2020

Figure 184: Dassault Systèmes: Overall Product Portfolio

All rights reserved at BIS Research Inc. 25

Figure 185: Dassault Systèmes: Overall Financials, $Million, 2018-2020

Figure 186: Dassault Systèmes: Net Revenue (by Segment), $Million, 2018-2020

Figure 187: Dassault Systèmes: Net Revenue (by Region), $Million, 2018-2020

Figure 188: Dassault Systèmes: R&D Expenditure, $Million, 2019-2021

Figure 189: IXICO plc: Overall Product Portfolio

Figure 190: IXICO plc: Overall Financials, $Million, 2019-2021

Figure 191: IXICO plc: R&D Expenditure, $Million, 2019-2021

Figure 192: IXICO plc: Revenue (by Region), $Million, 2020-2021

Figure 193: Koninklijke Philips N.V.: Overall Product Portfolio

Figure 194: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021

Figure 195: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2019-2021

Figure 196: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2019-2021

Figure 197: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021

Figure 198: Shimmer: Overall Product Portfolio

Figure 199: Quanterix Corporation: Overall Product Portfolio

Figure 200: Quanterix Corporation: Overall Financials, $Million, 2018-2020

Figure 201: Quanterix Corporation: Net Revenue (by Segment), $Million, 2018-2020

Figure 202: Quanterix Corporation: Net Revenue (by Region), $Million, 2018-2020

Figure 203: Quanterix Corporation: R&D Expenditure, $Million, 2018-2020

Figure 204: Altoida, AG: Overall Product Portfolio

Figure 205: Evidation Health, Inc.: Overall Product Portfolio

Figure 206: Happify, Inc.: Overall Product Portfolio

Figure 207: Huma: Overall Product Portfolio

Figure 208: Human API: Overall Product Portfolio

Figure 209: Mindstrong Health: Overall Product Portfolio

Figure 210: Neurotrack Technologies, Inc.: Overall Product Portfolio

Figure 211: Orikami: Overall Product Portfolio

Figure 212: Winterlight Labs, Inc.: Overall Product Portfolio

All rights reserved at BIS Research Inc. 26

List of Tables
Table 1: Challenges in the Global Digital Biomarkers Market

Table 2: Global Digital Biomarkers: Key Trends

Table 3: Awaited Technological Developments in the Global Digital Biomarkers Market

Table 4: Summary Of Research Studies Performed on Screening, Tracking, and Prevention of COVID-
19

Table 5: Features of Major Wearable Devices

Table 6: Global Digital Biomarkers Market, Major FDA Clearances, 2022

Table 7: Commercially Available Mobile Applications Used for Monitoring and Managing Inflammatory
Bowel’s Disease

Table 8: Key Developments in the Gastrointestinal Diseases Space Using Digital Health

Table 9: Key Developments in Sleep and Movement Disorders Using Digital Health

Table 10: Key Developments in Cardiovascular Diseases Space Using Digital Health

Table 11: Key Developments in the Mood-Related Disorders Space Using Digital Health

Table 12: Key Developments in Chronic Pain Space Using Digital Health

Table 13: Key Developments in Neurodegenerative Disorders Space Using Digital Health

Table 14: Key Developments in Diabetes Space Using Digital Health

Table 15: Leading Respiratory Conditions and its Incidence (in Million)

Table 16: Key Developments in Respiratory Diseases Space Using Digital Health

Table 17: Commercial Products Available, Implantable Devices

Table 18: North America Digital Biomarkers Market: Regulatory Framework

Table 19: North America Digital Biomarkers Market, Impact Analysis

Table 20: Europe Digital Biomarkers Market Regulatory Framework

Table 21: Challenges in MDR Implementation

Table 22: Europe Digital Biomarkers Market, Impact Analysis

Table 23: Asia-Pacific Digital Biomarkers Market Regulatory Framework

Table 24: Asia-Pacific Digital Biomarkers Market, Impact Analysis

Table 25: Latin America Digital Biomarkers Market Regulations

Table 26: Latin America Digital Biomarkers Market, Impact Analysis

Table 27: Rest-of-the-World Digital Biomarkers Market, Impact Analysis

All rights reserved at BIS Research Inc. 27

BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and
institutions worldwide and assist them with market intelligence in the area of emerging technologies,
advisories, and other innovative solutions.

Know More Know More Know More

Know More

All rights reserved at BIS Research Inc. 28

Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set
henceforth. This document and its contents are confidential and may not be further distributed, published, or
reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written
consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any
media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit
the use of Information to generate any statistical or other information that is or will be provided to third
parties; or voluntarily produce Information in legal proceedings.

Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that,
while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject
to market fluctuations and business, economic and competitive uncertainties, and contingencies

For more details regarding permission, please contact us:

Email: [email protected]
Tel: +1 510 404 8135

All rights reserved at BIS Research Inc. 29

 BIS RESEARCH INC.

39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686

E-mail: [email protected] | Call Us: +1-510-404-8135

Global Delivery Center

Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,

Sector 126, Noida, U.P., 201303, India

Tel: +91 120 4261540 / 4261544

All rights reserved at BIS Research Inc. 30

www.bisresearch.com